Synairgen - a drug discovery company specialising in respiratory diseases with a focus on asthma and chronic obstructive pulmonary disease COPD

Synairgen

OVERVIEW

The website synairgen.com presently has an average traffic classification of zero (the lower the higher page views). We have downloaded five pages inside the web site synairgen.com and found two websites linking to synairgen.com. There are two contacts and directions for synairgen.com to help you reach them. The website synairgen.com has been online for one thousand one hundred and forty-five weeks, ten days, four hours, and twenty-nine minutes.
Pages Parsed
5
Links to this site
2
Contacts
2
Addresses
2
Online Since
Mar 2003

SYNAIRGEN.COM TRAFFIC

The website synairgen.com is seeing alternating levels of traffic all over the year.
Traffic for synairgen.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for synairgen.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for synairgen.com

Date Range

All time
This Year
Last Year
Last Month

SYNAIRGEN.COM HISTORY

The website synairgen.com was first submitted to the registrar on March 19, 2003. This site will expire on March 19, 2015. As of today, it is one thousand one hundred and forty-five weeks, ten days, four hours, and twenty-nine minutes old.
REGISTERED
March
2003
EXPIRED
March
2015

AGE

21
YEARS
11
MONTHS
6
DAYS

LINKS TO SYNAIRGEN.COM

Lung Diseases

Publié par Benjamin de Bélizal.

WHAT DOES SYNAIRGEN.COM LOOK LIKE?

Desktop Screenshot of synairgen.com Mobile Screenshot of synairgen.com Tablet Screenshot of synairgen.com

CONTACTS

Synairgen Limited

Centre Block, Southampton General Hospital, Tremona Road

Southampton, SO16 6YD

GB

Synairgen Limited

Centre Block, Southampton General Hospital, Tremona Road

Southampton, SO16 6YD

GB

SYNAIRGEN.COM SERVER

I found that a single root page on synairgen.com took four hundred and twenty-two milliseconds to come up. We could not detect a SSL certificate, so therefore we consider this site not secure.
Load time
0.422 sec
SSL
NOT SECURE
IP
31.193.3.156

NAME SERVERS

ns19.domaincontrol.com
ns20.domaincontrol.com

FAVICON

SITE TITLE

Synairgen - a drug discovery company specialising in respiratory diseases with a focus on asthma and chronic obstructive pulmonary disease COPD

DESCRIPTION

Synairgen

PARSED CONTENT

The website states the following, "A drug discovery and development company." I viewed that the web site also stated " Focused on advancing novel approaches for." They also said " Research collaboration with Pharmaxis in IPF. AstraZeneca commences AZD9412 Phase II trial in severe asthma. Results of 2015 Annual General Meeting. Posting of annual report and accounts. Preliminary results for the year ended 31 December 2014. Registered in England and Wales. Mailpoint 810, Level F, South Block,. Southampton, SO16 6YD, UK."

SEE SUBSEQUENT BUSINESSES

Vente de banc détude déolienne PACA - Synairgie

Recherche et développement éolienne Bouches du Rhône. Carte SYNAIRGIE V3 pour module SCHEUTEN.

Air comprimé, synAIRgies - compresseur à vis occasion

Aller à la première colonne. Aller à la seconde colonne. ATLAS COPCO, KAESER, INGERSOLL RAND, BOGE, COMPAIR . Type Atlas Copco GA, Kaeser CSD, SSR. Industrie agroalimentaire, textile, chimique, cimenterie, minoterie, .

SYNAIRGIS Solutions de gestion - Conception de bâtiments LEED - Mise en service de bâtiments - Efficacité énergétique

Bâtiment durable - Certification et Gestion. Promoteurs et gestionnaires - Gestion de certification. Concepteurs - Processus de certification et soutien technique. Entrepreneurs en construction - Soutien technique et formation. Mise en service de bâtiments. Agent de Mise en Service LEED independant. Coordonnateur Mise en Service pour entrepreneurs. Installation et mise en service.

synaisthe - home

The easiest way to manage your class. Digital Medias and Performance Research. Synesthesia - is a neurologically-based condition in which stimulation of one sensory or cognitive pathway leads to automatic, involuntary experiences in a second sensory or cognitive pathway.